<code id='7F325BD575'></code><style id='7F325BD575'></style>
    • <acronym id='7F325BD575'></acronym>
      <center id='7F325BD575'><center id='7F325BD575'><tfoot id='7F325BD575'></tfoot></center><abbr id='7F325BD575'><dir id='7F325BD575'><tfoot id='7F325BD575'></tfoot><noframes id='7F325BD575'>

    • <optgroup id='7F325BD575'><strike id='7F325BD575'><sup id='7F325BD575'></sup></strike><code id='7F325BD575'></code></optgroup>
        1. <b id='7F325BD575'><label id='7F325BD575'><select id='7F325BD575'><dt id='7F325BD575'><span id='7F325BD575'></span></dt></select></label></b><u id='7F325BD575'></u>
          <i id='7F325BD575'><strike id='7F325BD575'><tt id='7F325BD575'><pre id='7F325BD575'></pre></tt></strike></i>

          focus

          focus

          author:leisure time    Page View:2223
          Illustration of doctors and researchers using innovative technologies for medicine and healthcare with artificial intelligence. -- health tech coverage from STAT
          Adobe

          At first glance, the Coalition for Health AI looks like any technology lobbying group. Its membership — including Microsoft, Google, and many of the nation’s largest academic hospitals — forms a formidable presence in Washington.

          But on Monday, the coalition forged a different deal with federal regulators. It will work with them to develop quality and safety standards for artificial intelligence, an experiment that will test whether industry and government can effectively partner in the regulation of a fast-moving technology.

          advertisement

          The nonprofit announced that its board of directors will include leaders from the Food and Drug Administration and the Office of the National Coordinator for Health Information Technology — agencies that, until now, have been setting up guardrails for AI in health care on their own. Government staffers will now work alongside industry scientists to develop evaluation methods and address new questions posed by generative AI and its emerging applications.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal
          Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

          CourtesySanofiLONDON—Inabidtoexpanditspipelineofinflammation-targetingdrugs,SanofisaidTuesdayitwasac

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          Teacher posts viral 'school supply rant' with advice for parents

          1:28TeacherKatieAlburgerholdsupafidgettoolwhileshoppingforback-to-schoolsupplies.@_adaywithmissa/Tik